DRUG BINDING INTERFACES MAPPED TO '3cs9'

List of Binding Interfaces
(Click on the entry ID to view details of interfaces and pattern clusters)
(Note that ASSAM search use only 3-12 residue containing patterns)

Filter list by:

DrReposER ID	PDB	Ligand	Organism	Macromolecule	Pfam	Res.	Interface	HETATM
3CS9_A_NILA600	3cs9	NIL DB04868 (Nilotinib)	Homo sapiens	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1	PF07714 (Pkinase_Tyr)	22	LEU A 248 TYR A 253 VAL A 256 ALA A 269 LYS A 271 LYS A 285 GLU A 286 VAL A 289 MET A 290 ILE A 293 LEU A 298 VAL A 299 ILE A 313 THR A 315 PHE A 317 GLY A 321 PHE A 359 HIS A 361 LEU A 370 VAL A 379 ALA A 380 ASP A 381	NIL A 600
3CS9_B_NILB600	3cs9	NIL DB04868 (Nilotinib)	Homo sapiens	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1	no annotation	21	LEU B 248 TYR B 253 VAL B 256 ALA B 269 LYS B 271 GLU B 286 VAL B 289 MET B 290 ILE B 293 LEU B 298 VAL B 299 ILE B 313 THR B 315 GLY B 321 PHE B 359 HIS B 361 LEU B 370 VAL B 379 ALA B 380 ASP B 381 PHE B 382	NIL B 600
3CS9_C_NILC600	3cs9	NIL DB04868 (Nilotinib)	Homo sapiens	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1	no annotation	21	LEU C 248 TYR C 253 VAL C 256 ALA C 269 LYS C 271 GLU C 286 VAL C 289 MET C 290 ILE C 293 LEU C 298 VAL C 299 ILE C 313 THR C 315 PHE C 317 MET C 318 PHE C 359 HIS C 361 VAL C 379 ALA C 380 ASP C 381 PHE C 382	NIL C 600
3CS9_D_NILD600	3cs9	NIL DB04868 (Nilotinib)	Homo sapiens	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1	no annotation	18	LEU D 248 TYR D 253 VAL D 256 ALA D 269 LYS D 271 GLU D 286 VAL D 289 MET D 290 ILE D 293 LEU D 298 THR D 315 PHE D 317 GLY D 321 PHE D 359 HIS D 361 LEU D 370 ALA D 380 ASP D 381	NIL D 600

[["3CS9_A_NILA600","3cs9","NIL","DB04868(Nilotinib)","Homo sapiens","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","PF07714(Pkinase_Tyr)",22,"LEU A 248;TYR A 253;VAL A 256;ALA A 269;LYS A 271;LYS A 285;GLU A 286;VAL A 289;MET A 290;ILE A 293;LEU A 298;VAL A 299;ILE A 313;THR A 315;PHE A 317;GLY A 321;PHE A 359;HIS A 361;LEU A 370;VAL A 379;ALA A 380;ASP A 381","NIL A 600\r"],["3CS9_B_NILB600","3cs9","NIL","DB04868(Nilotinib)","Homo sapiens","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","no annotation",21,"LEU B 248;TYR B 253;VAL B 256;ALA B 269;LYS B 271;GLU B 286;VAL B 289;MET B 290;ILE B 293;LEU B 298;VAL B 299;ILE B 313;THR B 315;GLY B 321;PHE B 359;HIS B 361;LEU B 370;VAL B 379;ALA B 380;ASP B 381;PHE B 382","NIL B 600\r"],["3CS9_C_NILC600","3cs9","NIL","DB04868(Nilotinib)","Homo sapiens","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","no annotation",21,"LEU C 248;TYR C 253;VAL C 256;ALA C 269;LYS C 271;GLU C 286;VAL C 289;MET C 290;ILE C 293;LEU C 298;VAL C 299;ILE C 313;THR C 315;PHE C 317;MET C 318;PHE C 359;HIS C 361;VAL C 379;ALA C 380;ASP C 381;PHE C 382","NIL C 600\r"],["3CS9_D_NILD600","3cs9","NIL","DB04868(Nilotinib)","Homo sapiens","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","no annotation",18,"LEU D 248;TYR D 253;VAL D 256;ALA D 269;LYS D 271;GLU D 286;VAL D 289;MET D 290;ILE D 293;LEU D 298;THR D 315;PHE D 317;GLY D 321;PHE D 359;HIS D 361;LEU D 370;ALA D 380;ASP D 381","NIL D 600\r"]]